Studies in England have found that the combination of low vitamin D levels and mononucleosis might raise a person's risk for multiple sclerosis. As someone who's had mono not once, but twice, and has low levels of vitamin D (thanks working in an office all day), I'd kind of like to know if that's true or not.
Researchers at Scripps Florida claim to be able to stop MS in mice by knocking out TH17, a malfunctioning white blood cell in patients with MS and other autoimmune diseases. While they may not be sure if it's a treatment or a cure, it still sounds cool--would also be awesome if patients could take a pill rather than giving themselves injections every day!
The US Patent Office has approved a new patent for Acorda's AMPYRA. It is approved as a treatment to improve walking in patients with MS. I wonder if it would also work for patients with Parkinson's.
Also, the National MS Society has a variety of Walk MS events going on throughout the spring across the country. The National Capital Chapter just rounded out their series of walks this weekend. Over the summer, various chapters will be hosting bike rides, mud runs, luncheons, and golf tournaments, and in the fall Challenge Walks will begin. If you are interested in getting involved with one of these events, contact your local chapter.
No comments:
Post a Comment